AbSci Develops GameChanging 12Week Cell Line Optimization Workflow and Adds Two New Members to Its Executive Team

AbSci Develops Game-Changing 12-Week Cell Line Optimization Workflow and Adds Two New Members to Its Executive Team

07:20 EDT 7 Apr 2019 | Synbiobeta

VANCOUVER, Wash., April 5, 2019 /PRNewswire/ — AbSci, a global leader in biotherapeutic discovery and manufacturing technologies, today announced the unveiling of their 12-week cell line optimization workflow and the addition of two executive team members: Martina Molsbergen, Vice President, Business Development and Johan Kers, PhD, Vice President, Research. Martina Molsbergen, AbSci’s new Vice President of […]

AbSci Develops GameChanging 12Week Cell Line Optimization Workflow and Adds Two New Members to Its Executive Team

AbSci Develops Game-Changing 12-Week Cell Line Optimization Workflow and Adds Two New Members to Its Executive Team

More From BioPortfolio on "AbSci Develops Game-Changing 12-Week Cell Line Optimization Workflow and Adds Two New Members to Its Executive Team"